🇺🇸 FDA
Pipeline program

A study understanding how much CDR132L enters the bloodstream after injection under the skin compared to injection into a vein in healthy participants

NN6706-8230

Phase 1 other active

Quick answer

A study understanding how much CDR132L enters the bloodstream after injection under the skin compared to injection into a vein in healthy participants for Healthy volunteers, treatment for heart failure is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Healthy volunteers, treatment for heart failure
Phase
Phase 1
Modality
other
Status
active

Clinical trials